{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:12:25Z","timestamp":1790622745857,"version":"4.1.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00204-018-2244-6","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T02:24:05Z","timestamp":1529288645000},"page":"2457-2473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects"],"prefix":"10.1007","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-4865","authenticated-orcid":false,"given":"Brian A.","family":"Baldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"2244_CR1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JCP.0000000000000344","volume":"35","author":"D Abadie","year":"2015","unstructured":"Abadie D, Rousseau V, Logerot S et al (2015) Serotonin syndrome. Analysis of cases registered in the French Pharmacovigilance Database. J Clin Psychopharmacol 35:382\u2013388","journal-title":"J Clin Psychopharmacol"},{"key":"2244_CR2","first-page":"1406","volume":"149","author":"NS Achamallah","year":"1992","unstructured":"Achamallah NS (1992) Visual hallucinations after combining fluoxetine and dextromethorphan. Am J Psychiatry 149:1406","journal-title":"Am J Psychiatry"},{"key":"2244_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10620-009-0711-x","volume":"55","author":"AA Alkhatib","year":"2010","unstructured":"Alkhatib AA, Peterson KA, Tuteja AK (2010) Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 55:215\u2013216","journal-title":"Dig Dis Sci"},{"key":"2244_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2710.2007.00813.x","volume":"32","author":"S Allawadhi","year":"2007","unstructured":"Allawadhi S, Sung KW, Carlson LA et al (2007) Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 32:199\u2013202","journal-title":"J Clin Pharm Ther"},{"key":"2244_CR5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1213\/ANE.0b013e3181c76be9","volume":"110","author":"CS Altman","year":"2010","unstructured":"Altman CS, Jahangiri MF (2010) Serotonin syndrome in the perioperative period. Anesth Analg 110:526\u2013528","journal-title":"Anesth Analg"},{"key":"2244_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1176\/appi.psy.48.4.361-a","volume":"48","author":"EM Altman","year":"2007","unstructured":"Altman EM, Manos GH (2007) Serotonin syndrome associated with citalopram and meperidine. Psychosomatics 48:361\u2013363","journal-title":"Psychosomatics"},{"key":"2244_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(89)90178-7","volume":"161","author":"J Arnt","year":"1989","unstructured":"Arnt J, Hyttel J (1989) Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Eur J Pharmacol 161:45\u201351","journal-title":"Eur J Pharmacol"},{"key":"2244_CR8","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1002\/phar.1601","volume":"35","author":"TJ Atkinson","year":"2015","unstructured":"Atkinson TJ, Fudin J (2015) Combined fentanyl and methadone induced serotonin syndrome is called into question. Pharmacotherapy 35:e111\u2013e114","journal-title":"Pharmacotherapy"},{"key":"2244_CR9","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jaip.2017.04.028","volume":"5","author":"BA Baldo","year":"2017","unstructured":"Baldo BA (2017) Editorial. Opioid analgesic drugs: Misuse, toxicity, and hypersensitivity. J Allergy Clin Immunol 5:1607\u20131608","journal-title":"J Allergy Clin Immunol"},{"key":"2244_CR10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","volume":"40","author":"BA Baldo","year":"2012","unstructured":"Baldo BA, Pham NH (2012) Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesth Intensive Care 40:216\u2013235","journal-title":"Anaesth Intensive Care"},{"key":"2244_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4614-7261-2","volume-title":"Drug allergy: clinical aspects, diagnosis, mechanisms, structure-activity relationships","author":"BA Baldo","year":"2013","unstructured":"Baldo BA, Pham NH (2013) Drug allergy: clinical aspects, diagnosis, mechanisms, structure-activity relationships. Springer, New York, pp\u00a0303\u2013308"},{"key":"2244_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.054","volume":"531","author":"M Barann","year":"2006","unstructured":"Barann M, Urban B, Stamer U et al (2006) Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol 531:54\u201358","journal-title":"Eur J Pharmacol"},{"key":"2244_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00210-014-1056-3","volume":"388","author":"M Barann","year":"2015","unstructured":"Barann M, Stamer UM, Lyutenska M et al (2015) Effects of opioids on human serotonin transporters. Naunyn Schmiedeberg\u2019s Arch Pharmacol 388:43\u201349","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2244_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/mol.53.4.649","volume":"53","author":"D Bengel","year":"1998","unstructured":"Bengel D, Murphy DL, Andrews AM et al (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) in serotonin transporter-deficient mice. Mol Pharmacol 53:649\u2013655","journal-title":"Mol Pharmacol"},{"key":"2244_CR15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M (2005) The serotonin syndrome. N Eng J Med 352:1112\u20131120","journal-title":"N Eng J Med"},{"key":"2244_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.14740\/jmc2702e","volume":"7","author":"A Caamano","year":"2016","unstructured":"Caamano A, Din R, Eter A (2016) Serotonin syndrome induced by combined use of tramadol and escitalopram: a case report. J Med Cases 7:554\u2013557","journal-title":"J Med Cases"},{"key":"2244_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.18773\/austprescr.2006.044","volume":"29","author":"C Cameron","year":"2006","unstructured":"Cameron C (2006) Serotonin syndrome precipitated by an over-the-counter cold remedy. Aust Prescr 29:71. https:\/\/doi.org\/10.18773\/austprescr.2006.044","journal-title":"Aust Prescr"},{"key":"2244_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5694\/j.1326-5377.1998.tb123399.x","volume":"169","author":"BS Chan","year":"1998","unstructured":"Chan BS, Graudins A, Whyte IM et al (1998) Serotonin syndrome resulting from drug interactions. Med J Aust 169:523\u2013525","journal-title":"Med J Aust"},{"key":"2244_CR19","first-page":"2086","volume":"8","author":"M Chassot","year":"2012","unstructured":"Chassot M, Munz T, Livio F et al (2012) Syndrome s\u00e9rotoninergique: mise au point et revue des cas annonc\u00e9s en Suisse. Rev Med Suisse 8:2086\u20132090","journal-title":"Rev Med Suisse"},{"key":"2244_CR20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","volume":"48","author":"ZR Chen","year":"1991","unstructured":"Chen ZR, Irvine RJ, Somogyi AA et al (1991) Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 48:2165\u20132171","journal-title":"Life Sci"},{"key":"2244_CR21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/15563650701606443","volume":"45","author":"PA Chyka","year":"2007","unstructured":"Chyka PA, Erdman AR, Manoguerra AS et al (2007) Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 45:662\u2013677","journal-title":"Clin Toxicol"},{"key":"2244_CR22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pds.1113","volume":"14","author":"TJ Cicero","year":"2005","unstructured":"Cicero TJ, Inciardi JA, Adams EH et al (2005) Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994\u20132004. Pharmacoepidemiol Drug Saf 14:851\u2013859","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2244_CR23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0736-4679(95)02002-0","volume":"13","author":"RF Clark","year":"1995","unstructured":"Clark RF, Wei EM, Anderson PO (1995) Meperidine: therapeutic use and toxicity. J Emerg Med 13:797\u2013802","journal-title":"J Emerg Med"},{"key":"2244_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0379-0738(03)00100-2","volume":"134","author":"F Clarot","year":"2003","unstructured":"Clarot F, Goull\u00e9 J-P, Vaz E et al (2003) Fatal overdoses of tramadol: is benzodiazepine a risk factor for lethality? Forensic Sci Int 134:57\u201361","journal-title":"Forensic Sci Int"},{"key":"2244_CR25","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-3565(25)10630-7","volume":"274","author":"EE Codd","year":"1995","unstructured":"Codd EE, Shank RP, Schupsky JJ et al (1995) Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics. J Pharmacol Exp Ther 274:1263\u20131270","journal-title":"J Pharmacol Exp Ther"},{"key":"2244_CR26","first-page":"837","volume":"150","author":"JD Coplan","year":"1993","unstructured":"Coplan JD, Gorman JM (1993) Detectable levels of fluoxetine after discontinuation. An unexpected serotonin syndrome. Am J Psychiatry 150:837","journal-title":"Am J Psychiatry"},{"key":"2244_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(24)37948-0","volume":"288","author":"NA Darmani","year":"1999","unstructured":"Darmani NA, Ahmad B (1999) Long-term sequential determination of behavioral ontogeny of 5-HT1 And 5-HT2 receptor functions in the rat. J Pharmacol Exp Ther 288:247\u2013253","journal-title":"J Pharmacol Exp Ther"},{"key":"2244_CR28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/15563650701438847","volume":"45","author":"C Daubin","year":"2007","unstructured":"Daubin C, Quentin C, Goull\u00e9 J-P et al (2007) Refractory shock and asystole related to tramadol overdose. Clin Toxicol 45:961\u2013964","journal-title":"Clin Toxicol"},{"key":"2244_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00520-002-0385-9","volume":"11","author":"MP Davis","year":"2003","unstructured":"Davis MP, Varga J, Dickersen D et al (2003) Normal-release and controlled-release oxycodone: pharmacokinetics, phamacodynamics, and controversy. Support Care Cancer 11:84\u201392","journal-title":"Support Care Cancer"},{"key":"2244_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1476-5381.1992.tb14226.x","volume":"105","author":"B Driessen","year":"1992","unstructured":"Driessen B, Reimann W (1992) Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 105:147\u2013151","journal-title":"Br J Pharmacol"},{"key":"2244_CR31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1476-5381.1993.tb12882.x","volume":"108","author":"B Driessen","year":"1993","unstructured":"Driessen B, Reimann W, Giertz H (1993) Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 108:806\u2013811","journal-title":"Br J Pharmacol"},{"key":"2244_CR32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","volume":"96","author":"EJ Dunkley","year":"2003","unstructured":"Dunkley EJ, Isbister GK, Sibbritt D (2003) The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 96:635\u2013642","journal-title":"QJM"},{"key":"2244_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/bja\/59.1.61","volume":"59","author":"DJR Duthie","year":"1987","unstructured":"Duthie DJR, Nimmo WS (1987) Adverse effects of opioid analgesic drugs. Br J Anaesth 59:61\u201377","journal-title":"Br J Anaesth"},{"key":"2244_CR34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199705000-00010","volume":"12","author":"AC Egberts","year":"1997","unstructured":"Egberts AC, ter Borgh J, Brodie-Meijer CC (1997) Serotonin syndrome attributed to tramadol addition to paroxetine therapy. Int Clin Psychopharmacol 12:181\u2013182","journal-title":"Int Clin Psychopharmacol"},{"key":"2244_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0091-3057(92)90649-Z","volume":"43","author":"AS Eison","year":"1992","unstructured":"Eison AS, Wright RN (1992) 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil. Pharmacol Biochem Behav 43:131\u2013137","journal-title":"Pharmacol Biochem Behav"},{"key":"2244_CR36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1526-4610.2010.01691.x","volume":"50","author":"RW Evans","year":"2010","unstructured":"Evans RW, Tepper SJ, Shapiro RE et al (2010) The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache 50:1089\u20131099","journal-title":"Headache"},{"key":"2244_CR37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.psym.2013.05.013","volume":"55","author":"BA Falls","year":"2014","unstructured":"Falls BA, Gurrera RJ (2014) Serotonin syndrome in a patient on tramadol, bupropion, trazodone, and oxycodone. Psychosomatics 55:305\u2013309","journal-title":"Psychosomatics"},{"key":"2244_CR38","unstructured":"FDA Drug safety communications (2016) FDA warns about several safety issues with opioid pain medicines; requires label changes. March 22, 2016. https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM491302.pdf . Accessed 30 January 2018"},{"key":"2244_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(95)00234-C","volume":"281","author":"EA Forster","year":"1995","unstructured":"Forster EA, Cliffe IA, Bill DJ et al (1995) A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81\u201388","journal-title":"Eur J Pharmacol"},{"key":"2244_CR40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","volume":"53","author":"MA Fox","year":"2007","unstructured":"Fox MA, Jensen CL, Gallagher PS et al (2007) Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacol 53:643\u2013656","journal-title":"Neuropharmacol"},{"key":"2244_CR41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1017\/S146114570900011X","volume":"12","author":"MA Fox","year":"2009","unstructured":"Fox MA, Jensen CL, Murphy DL (2009) Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioral effects, but decreased analgesic effects, in genetically-deficient serotonin transporter (SERT) mice. Int J Neuropsychopharmacol 12:1055\u20131065","journal-title":"Int J Neuropsychopharmacol"},{"key":"2244_CR42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/tpj.2012.35","volume":"13","author":"MA Fox","year":"2013","unstructured":"Fox MA, Panessiti MG, Moya PR et al (2013) Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans. Pharmacogenomics J 13:551\u2013557","journal-title":"Pharmacogenomics J"},{"key":"2244_CR43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAF.0b013e3182887804","volume":"35","author":"DM Franco","year":"2014","unstructured":"Franco DM, Ali Z, Levine B et al (2014) Case report of a fatal intoxication by Nucynta. Am J Forensic Med Pathol 35:234\u2013236","journal-title":"Am J Forensic Med Pathol"},{"key":"2244_CR44","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4020-5947-6","volume-title":"Opioids in medicine","author":"E Freye","year":"2008","unstructured":"Freye E (2008) Opioids in medicine. Springer, Dordrecht"},{"key":"2244_CR45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PEC.0b013e31815a0667","volume":"23","author":"M Ganetsky","year":"2007","unstructured":"Ganetsky M, Babu KM, Boyer EW (2007) Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care 23:829\u2013831","journal-title":"Pediatr Emerg Care"},{"key":"2244_CR46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0310057X0403200417","volume":"32","author":"PM Garrett","year":"2004","unstructured":"Garrett PM (2004) Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction. Anaesth Intensive Care 32:575\u2013577","journal-title":"Anaesth Intensive Care"},{"key":"2244_CR47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1592\/phco.20.7.629.35174","volume":"20","author":"C Gasse","year":"2000","unstructured":"Gasse C, Derby L, Vasilakis-Scaramozza C et al (2000) Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 20:629\u2013634","journal-title":"Pharmacotherapy"},{"key":"2244_CR48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/978-1-4614-8948-1_49","volume-title":"Essentials of pharmacology for anesthesia, pain medicine, and critical care","author":"JA Gayle","year":"2015","unstructured":"Gayle JA, Volpi-Abadie J, Kaye AM et al (2015) Serotonin syndrome. In: Kaye AD, Kaye AM, Urman RD (eds) Essentials of pharmacology for anesthesia, pain medicine, and critical care. Springer, New York, pp\u00a0797\u2013807"},{"key":"2244_CR49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/026988119901300111","volume":"13","author":"PK Gillman","year":"1999","unstructured":"Gillman PK (1999) The serotonin syndrome and its treatment. J Psychopharmacol 13:100\u2013109","journal-title":"J Psychopharmacol"},{"key":"2244_CR50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","volume":"95","author":"PK Gillman","year":"2005","unstructured":"Gillman PK (2005) Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 95:434\u2013441","journal-title":"Br J Anaesth"},{"key":"2244_CR51","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.biopsych.2005.11.016","volume":"59","author":"PK Gillman","year":"2006","unstructured":"Gillman PK (2006a) A review of serotonin toxicity data: Implications for the mechanisms of antidepressant drug action. Biol Psychiatry 59:1046\u20131051","journal-title":"Biol Psychiatry"},{"key":"2244_CR52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2044.2006.04588.x","volume":"61","author":"PK Gillman","year":"2006","unstructured":"Gillman PK (2006b) Extracting value from case reports: lessons from serotonin toxicity. Anaesthesia 61:419\u2013422","journal-title":"Anaesthesia"},{"key":"2244_CR53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1526-4610.2009.01575.x","volume":"50","author":"PK Gillman","year":"2010","unstructured":"Gillman PK (2010) Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache 50:264\u2013272","journal-title":"Headache"},{"key":"2244_CR54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/med\/9780198527480.003.0003","volume-title":"Adverse syndromes and pschiatric drugs","author":"PK Gillman","year":"2004","unstructured":"Gillman PK, Whyte IM (2004) Serotonin syndrome. In: Haddad P, Dursun S, Deakin B (eds) Adverse syndromes and pschiatric drugs. Oxford University Press, Oxford, pp\u00a037\u201349"},{"key":"2244_CR55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.bjp.0701374","volume":"122","author":"P Giusti","year":"1997","unstructured":"Giusti P, Buriani A, Cima L et al (1997) Effect of acute and chronic tramadol on [3H]-5-HT uptake in rat cortical synaptosomes. Br J Pharmacol 122:302\u2013306","journal-title":"Br J Pharmacol"},{"key":"2244_CR56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jamda.2005.04.012","volume":"6","author":"N Gnanadesigan","year":"2005","unstructured":"Gnanadesigan N, Espinoza RT, Smith R et al (2005) Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected? J Am Med Dir Assoc 6:265\u2013269","journal-title":"J Am Med Dir Assoc"},{"key":"2244_CR57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jclinane.2011.04.017","volume":"24","author":"S Gollapudy","year":"2012","unstructured":"Gollapudy S, Kumar V, Dhamee MS (2012) A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion. J Clin Anesth 24:251\u2013252","journal-title":"J Clin Anesth"},{"key":"2244_CR58","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1176\/appi.ajp.158.6.964-a","volume":"158","author":"A Gonzalez-Pinto","year":"2001","unstructured":"Gonzalez-Pinto A, Imaz H, De Heredia JL et al (2001) Mania and tramadol-fluoxetine combination. Am J Psychiatry 158:964\u2013965","journal-title":"Am J Psychiatry"},{"key":"2244_CR59","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1476-5381.1985.tb16157.x","volume":"84","author":"GM Goodwin","year":"1985","unstructured":"Goodwin GM, Green AR (1985) A behavioral and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743\u2013753","journal-title":"Br J Pharmacol"},{"key":"2244_CR60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/15360288.2017.1416440","volume":"31","author":"LE Gressler","year":"2017","unstructured":"Gressler LE, Hammond DA, Painter JT et al (2017) Serotonin syndrome in tapentadol literature: systematic review of original research. J Pain Palliat Care Pharmacother 31:228\u2013236","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2244_CR61","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4140\/TCP.n.2009.833","volume":"24","author":"DR Guay","year":"2009","unstructured":"Guay DR (2009) Is tapentadol an advance on tramadol? Consult Pharm 24:833\u2013840","journal-title":"Consult Pharm"},{"key":"2244_CR62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/bja\/aep167","volume":"103","author":"S-L Guo","year":"2009","unstructured":"Guo S-L, Wu T-J, Liu C-C et al (2009) Meperidine-induced serotonin syndrome in a susceptible patient. Br J Anaesth 103:369\u2013370","journal-title":"Br J Anaesth"},{"key":"2244_CR63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2013.08.045","volume":"256","author":"R Haberzettl","year":"2013","unstructured":"Haberzettl R, Bert B, Fink H et al (2013) Animal models of the serotonin syndrome: a systematic review. Behav Brain Res 256:328\u2013345","journal-title":"Behav Brain Res"},{"key":"2244_CR64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.vascn.2014.07.003","volume":"70","author":"R Haberzettl","year":"2014","unstructured":"Haberzettl R, Fink H, Bert B (2014) Role of 5-HT1A and 5-HT2A receptors for the murine model of the serotonin syndrome. J Pharmacol Toxicol Methods 70:129\u2013133","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"9247","key":"2244_CR65","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(00)03409-7","volume":"356","author":"K Herrlin","year":"2000","unstructured":"Herrlin K, Segerdahl M, Gustafsson LL et al (2000) Methadone, ciprofloxacin, and adverse drug reactions. Lancet 356(9247):2069\u20132070","journal-title":"Lancet"},{"key":"2244_CR66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/phar.1528","volume":"35","author":"AD Hillman","year":"2015","unstructured":"Hillman AD, Witenko CJ, Sultan SM et al (2015) Serotonin syndrome caused by fentanyl and methadone in a burn injury. Pharmacotherapy 35:112\u2013117","journal-title":"Pharmacotherapy"},{"key":"2244_CR67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1345\/aph.1D344","volume":"38","author":"DJ Houlihan","year":"2004","unstructured":"Houlihan DJ (2004) Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann Pharmacother 38:411\u2013413","journal-title":"Ann Pharmacother"},{"key":"2244_CR68","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1213\/00000539-199204000-00007","volume":"74","author":"RJ Houmes","year":"1992","unstructured":"Houmes RJ, Voets MA, Verkaaik A et al (1992) Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg 74:510\u2013514","journal-title":"Anesth Analg"},{"key":"2244_CR69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533\u2013554","journal-title":"Pharmacol Biochem Behav"},{"key":"2244_CR70","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1176\/ajp.139.7.954","volume":"139","author":"TR Insel","year":"1982","unstructured":"Insel TR, Roy BF, Cohen RM et al (1982) Possible development of the serotonin syndrome in man. Am J Psychol 139:954\u2013955","journal-title":"Am J Psychol"},{"key":"2244_CR71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.wnf.0000177642.89888.85","volume":"28","author":"GK Isbister","year":"2005","unstructured":"Isbister GK, Buckley NA (2005) The payhophysiology of serotonin to toxicity in animals and humans. Implications for diagnosis and treatment. Clin Neuropharmacol 28:205\u2013214","journal-title":"Clin Neuropharmacol"},{"key":"2244_CR72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120037428","volume":"42","author":"GK Isbister","year":"2004","unstructured":"Isbister GK, Bowe SJ, Dawson A et al (2004) Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 42:277\u2013285","journal-title":"J Toxicol Clin Toxicol"},{"key":"2244_CR73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5694\/j.1326-5377.2007.tb01282.x","volume":"187","author":"GK Isbister","year":"2007","unstructured":"Isbister GK, Buckley NA, Whyte IM (2007) Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust 187:361\u2013365","journal-title":"Med J Aust"},{"key":"2244_CR74","doi-asserted-by":"crossref","first-page":"840.e3","DOI":"10.1016\/j.ajem.2008.01.039","volume":"26","author":"D Isenberg","year":"2008","unstructured":"Isenberg D, Wong SC, Curtis JA (2008) Serotonin syndrome triggered by a single dose of suboxone. Am J Emerg Med 26:840.e3\u2013840.e5","journal-title":"Am J Emerg Med"},{"key":"2244_CR75","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/j.1875-9114.1998.tb03123.x","volume":"18","author":"H Jick","year":"1998","unstructured":"Jick H, Derby LE, Vasilakis C et al (1998) The risk of seizures associated with tramadol. Pharmacotherapy 18:607\u2013611","journal-title":"Pharmacotherapy"},{"key":"2244_CR76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4097\/kjae.2017.70.2.221","volume":"70","author":"S Joe","year":"2017","unstructured":"Joe S, Kim E, Park J et al (2017) Famotidine-induced reversal of meperidine-related serotonin syndrome\u2014a case report. Korean J Anesthesiol 70:221\u2013223","journal-title":"Korean J Anesthesiol"},{"key":"2244_CR77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/1556365050014418","volume":"44","author":"V Jovanovi\u0107-\u010cupi\u0107","year":"2006","unstructured":"Jovanovi\u0107-\u010cupi\u0107 V, Martinovi\u0107 \u017d, Ne\u0161i\u0107 N (2006) Seizures associated with intoxication and abuse of tramadol. Clin Toxicol 44:143\u2013146","journal-title":"Clin Toxicol"},{"key":"2244_CR78","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1997.03550200037026","volume":"278","author":"LH Kahn","year":"1997","unstructured":"Kahn LH, Alderfer RJ, Graham DJ (1997) Seizures reported with tramadol. JAMA 278:1661","journal-title":"JAMA"},{"issue":"5 Suppl","key":"2244_CR79","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jpainsymman.2005.01.010","volume":"29","author":"E Kalso","year":"2005","unstructured":"Kalso E (2005) Oxycodone. J Pain Symptom Manage 29(5 Suppl):S47\u2013S56","journal-title":"J Pain Symptom Manage"},{"key":"2244_CR80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1601-183X.2006.00270.x","volume":"6","author":"AV Kalueff","year":"2007","unstructured":"Kalueff AV, Fox MA, Gallagher PS et al (2007) Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6:389\u2013400","journal-title":"Genes Brain Behav"},{"key":"2244_CR81","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/15563650802403534","volume":"46","author":"PN Karamanakos","year":"2008","unstructured":"Karamanakos PN, Panteli ES (2008) Comment on: \u201cDextromethorphan-induced serotonin syndrome\u201d. Clin Toxicol 46:1101","journal-title":"Clin Toxicol"},{"key":"2244_CR82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1345\/aph.1E671","volume":"40","author":"H Karunatilake","year":"2006","unstructured":"Karunatilake H, Buckley NA (2006) Serotonin syndrome induced by fluvoxamine and oxycodone. Ann Pharmacother 40:155\u2013157","journal-title":"Ann Pharmacother"},{"key":"2244_CR83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2125.1994.tb04348.x","volume":"38","author":"NL Kerry","year":"1994","unstructured":"Kerry NL, Somogyi AA, Bochner F et al (1994) The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. Br J Clin Pharmacol 38:243\u2013248","journal-title":"Br J Clin Pharmacol"},{"key":"2244_CR84","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/014107689909200915","volume":"92","author":"S Kesavan","year":"1999","unstructured":"Kesavan S, Sobala GM (1999) Serotonin syndrome with fluoxetine plus tramadol. J Roy Soc Med 92:474\u2013475","journal-title":"J Roy Soc Med"},{"key":"2244_CR85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1447-0594.2010.00652.x","volume":"11","author":"H Kinoshita","year":"2011","unstructured":"Kinoshita H, Ohkubo T, Yasuda M et al (2011) Serotonin syndrome induced by dextromethorphan (Medicon) administered at the conventional dose. Geniatr Gerontol Int 11:121\u2013122","journal-title":"Geniatr Gerontol Int"},{"key":"2244_CR86","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jemermed.2008.01.003","volume":"38","author":"R Kirschner","year":"2010","unstructured":"Kirschner R, Donovan JW (2010) Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 38:477\u2013480","journal-title":"J Emerg Med"},{"key":"2244_CR87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0028-3908(01)00100-9","volume":"5","author":"K Kishimoto","year":"2001","unstructured":"Kishimoto K, Koyama S, Akaike N (2001) Synergistic \u00b5-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons. Neuropharmacol 5:529\u2013538","journal-title":"Neuropharmacol"},{"key":"2244_CR88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(85)90138-4","volume":"118","author":"F Koshikawa","year":"1985","unstructured":"Koshikawa F, Koshikawa N, Stephenson JD (1985) Effects of antidepressant drug combinations on corticol 5-HT receptors and wet dog-shakes in rats. Eur J Pharmacol 118:273\u2013281","journal-title":"Eur J Pharmacol"},{"key":"2244_CR89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/102490790701400109","volume":"14","author":"SW Kung","year":"2007","unstructured":"Kung SW, Ng MH (2007) Serotonin syndrome with tramadol and dextromethorphan. Hong Kong J Emerg Med 14:48\u201352","journal-title":"Hong Kong J Emerg Med"},{"key":"2244_CR90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5694\/j.1326-5377.2005.tb06556.x","volume":"182","author":"A Labate","year":"2005","unstructured":"Labate A, Newton MR (2005) Tramadol and new-onset seizures. Med J Aust 182:42\u201343","journal-title":"Med J Aust"},{"key":"2244_CR91","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004714-200208000-00022","volume":"22","author":"C Lange-Asschenfeldt","year":"2002","unstructured":"Lange-Asschenfeldt C, Weigmann H, Hiemke C et al (2002) Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level correlated symptomatology. J Clin Psychopharmacol 22:440\u2013441","journal-title":"J Clin Psychopharmacol"},{"key":"2244_CR92","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/(SICI)1099-1166(199805)13:5<343::AID-GPS771>3.0.CO;2-5","volume":"13","author":"MS Lantz","year":"1998","unstructured":"Lantz MS, Buchalter EN, Giambanco V (1998) Serotonin syndrome following the administration of tramadol with paroxetine. Int J Geriatr Psychiatry 13:343\u2013345","journal-title":"Int J Geriatr Psychiatry"},{"key":"2244_CR93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bcpt.1985.57.3.214","volume":"57","author":"JJ Larsen","year":"1985","unstructured":"Larsen JJ, Hyttel J (1985) 5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats. Acta Pharmacol Toxicol (Copenh) 57:214\u2013218","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"2244_CR94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00045391-200201000-00010","volume":"9","author":"KS Latta","year":"2002","unstructured":"Latta KS, Ginsberg B, Barkin RL (2002) Meperidine: a critical review. Am J Ther 9:53\u201368","journal-title":"Am J Ther"},{"key":"2244_CR95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0033-3182(09)70868-0","volume":"50","author":"J Lee","year":"2009","unstructured":"Lee J, Franz L, Goforth HW (2009) Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. Psychosomatics 50:638\u2013639","journal-title":"Psychosomatics"},{"key":"2244_CR96","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.genhosppsych.2008.03.008","volume":"30","author":"TT Levin","year":"2008","unstructured":"Levin TT, Cortes-Ladino A, Weiss M et al (2008) Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. Gen Hosp Psychiatry 30:372\u2013377","journal-title":"Gen Hosp Psychiatry"},{"key":"2244_CR97","volume-title":"Anaphylactic reactions in anesthesia and intensive care","author":"JH Levy","year":"1986","unstructured":"Levy JH (1986) Anaphylactic reactions in anesthesia and intensive care. Butterworths, Boston"},{"key":"2244_CR98","first-page":"871","volume":"49","author":"FJ Mackay","year":"1999","unstructured":"Mackay FJ, Dunn NR, Mann RD (1999) Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 49:871\u2013874","journal-title":"Br J Gen Pract"},{"key":"2244_CR99","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1176\/appi.ajp.161.6.1129","volume":"161","author":"R Mahlberg","year":"2004","unstructured":"Mahlberg R, Kunz D, Sasse J et al (2004) Serotonin syndrome with tramadol and citalopram. Am J Psychiatry 161:1129","journal-title":"Am J Psychiatry"},{"key":"2244_CR100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1310\/hpj4807-542","volume":"48","author":"MA Mancano","year":"2013","unstructured":"Mancano MA (2013) ISMP adverse drug reactions. Serotonin syndrome with concomitant use of tapentadol and venlafaxine. Hosp Pharm 48:542\u2013549","journal-title":"Hosp Pharm"},{"key":"2244_CR101","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pediatrneurol.2010.08.005","volume":"44","author":"C Mar\u00e9chal","year":"2011","unstructured":"Mar\u00e9chal C, Honorat R, Claudet I (2011) Serotonin syndrome induced by tramadol intoxication in an 8-month-old infant. Pediatr Neurol 44:72\u201374","journal-title":"Pediatr Neurol"},{"key":"2244_CR102","first-page":"42","volume":"51","author":"TT Martinez","year":"2008","unstructured":"Martinez TT, Martinez DN (2008) A case of serotonin syndrome associated with methadone overdose. Proc West Pharmacol Soc 51:42\u201344","journal-title":"Proc West Pharmacol Soc"},{"key":"2244_CR103","first-page":"154","volume":"4","author":"JF Martin-Lazaro","year":"2017","unstructured":"Martin-Lazaro JF, Hayde-West J, Chatzimichael S et al (2017) A dangerous triad: Sertraline, mirtazapine and methadone. Clin Med Rev Case Rep 4:154\u2013155","journal-title":"Clin Med Rev Case Rep"},{"key":"2244_CR104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/106002809703100208","volume":"31","author":"BJ Mason","year":"1997","unstructured":"Mason BJ, Blackburn KH (1997) Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother 31:175\u2013177","journal-title":"Ann Pharmacother"},{"key":"2244_CR105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005792-200007000-00001","volume":"79","author":"PJ Mason","year":"2000","unstructured":"Mason PJ, Morris VA, Balcezak TJ (2000) Serotonin syndrome. Presentation of two cases and review of the literature. Medicine (Baltimore) 79:201\u2013209","journal-title":"Medicine (Baltimore)"},{"key":"2244_CR106","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/0006-2952(73)90037-3","volume":"22","author":"MJ Mattila","year":"1973","unstructured":"Mattila MJ, Jounela AJ (1973) Effect of p-chlorophenylalanine on the interaction between phenelzine and pethidine in conscious rabbits. Biochem Pharmacol 22:1674\u20131676","journal-title":"Biochem Pharmacol"},{"key":"2244_CR107","first-page":"72","volume":"54","author":"T McDiarmid","year":"2005","unstructured":"McDiarmid T, Mackler L, Schneider DM (2005) Clinical inquiries. What is the addiction risk associated with tramadol? J Fam Pract 54:72\u201373","journal-title":"J Fam Pract"},{"key":"2244_CR108","first-page":"146","volume":"42","author":"M Mehrpour","year":"2005","unstructured":"Mehrpour M (2005) Intravenous tramadol-induced seizure: two case reports. Iran J Pharmacol Ther 42:146\u2013147","journal-title":"Iran J Pharmacol Ther"},{"key":"2244_CR109","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004714-198109000-00009","volume":"1","author":"D Meyer","year":"1981","unstructured":"Meyer D, Halfin V (1981) Toxicity secondary to meperidine in patients on monoamine oxidase inhibitors: a case report and critical review. J Clin Psychopharmacol 1:319\u2013321","journal-title":"J Clin Psychopharmacol"},{"key":"2244_CR110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.9758\/cpn.2017.15.3.292","volume":"15","author":"G Milano","year":"2017","unstructured":"Milano G, Natta WM, Bello A et al (2017) Codeine precipitating serotonin syndrome in a patient in therapy with antidepressant and triptan. Clin Psychopharmacol Neurosci 15:292\u2013295","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2244_CR111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","volume":"13","author":"KC Mills","year":"1997","unstructured":"Mills KC (1997) Serotonin syndrome. A clinical update. Crit Care Clin 13:763\u2013783","journal-title":"Crit Care Clin"},{"key":"2244_CR112","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-42-2-417","volume":"42","author":"RS Mitchell","year":"1955","unstructured":"Mitchell RS (1955) Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis. Ann Intern Med 42:417\u2013424","journal-title":"Ann Intern Med"},{"key":"2244_CR113","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00002826-200405000-00012","volume":"27","author":"D Mittino","year":"2004","unstructured":"Mittino D, Mula M, Monaco F (2004) Serotonin syndrome associated with tramadol-sertraline coadministration. Clin Neuropharmacol 27:150\u2013151","journal-title":"Clin Neuropharmacol"},{"key":"2244_CR114","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2125.2010.03747.x","volume":"70","author":"AA Monte","year":"2010","unstructured":"Monte AA, Chuang R, Bodmer M (2010) Dextromethorphan, chlorpheniramine and serotonin toxicity: case report and systematic literature review. Br J Clin Pharmacol 70:794\u2013798","journal-title":"Br J Clin Pharmacol"},{"key":"2244_CR115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00000433-199903000-00023","volume":"20","author":"KA Moore","year":"1999","unstructured":"Moore KA, Cina SJ, Jones R et al (1999) Tissue distribution of tramadol and metabolites in an overdose fatality. Am J Forensic Med Pathol 20:98\u2013100","journal-title":"Am J Forensic Med Pathol"},{"key":"2244_CR116","unstructured":"Morphine sulfate injection. Highlights of prescribing information (2016) Adverse reactions. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/204223s006lbl.pdf. Accessed 2 March 2018"},{"key":"2244_CR117","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1310\/hpx5204-246","volume":"52","author":"ME Mullins","year":"2017","unstructured":"Mullins ME, Dribben WH (2017) Comment on tapentadol and serotonin syndrome. Hosp Pharm 52:246\u2013247","journal-title":"Hosp Pharm"},{"key":"2244_CR118","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1360-0443.2008.02390.x","volume":"103","author":"MK Nair","year":"2008","unstructured":"Nair MK, Patel K, Starer PJ (2008) Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient. Addiction 103:2062\u20132064","journal-title":"Addiction"},{"key":"2244_CR119","doi-asserted-by":"crossref","first-page":"19P","DOI":"10.1113\/jphysiol.1950.sp004461","volume":"111","author":"PA Nasmyth","year":"1950","unstructured":"Nasmyth PA, Stewart HC (1950) The release of histamine by opium alkaloids. J Physiol 111:19P","journal-title":"J Physiol"},{"key":"2244_CR120","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","volume":"108","author":"DE Nichols","year":"2008","unstructured":"Nichols DE, Nichols CD (2008) Serotonin receptors. Chem Rev 108:1614\u20131641","journal-title":"Chem Rev"},{"key":"2244_CR121","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)03020-1","volume":"890","author":"K Nisijima","year":"2001","unstructured":"Nisijima K, Yoshino T, Yui K et al (2001) Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 890:23\u201331","journal-title":"Brain Res"},{"key":"2244_CR122","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2004-815526","volume":"37","author":"K Nisijima","year":"2004","unstructured":"Nisijima K, Shioda K, Yoshino T et al (2004) Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. Pharmacopsychiatry 37:57\u201362","journal-title":"Pharmacopsychiatry"},{"key":"2244_CR123","unstructured":"Nucynta\u00ae ER (Tapentadol). Highlights of prescribing information (2016) Warnings and precautions. Adverse reactions. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/200533s014lbl.pdf . Accessed 2 Mar 2018"},{"key":"2244_CR124","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.10.12.1076","volume":"10","author":"JA Oates","year":"1960","unstructured":"Oates JA, Sjoerdsma A (1960) Neurological effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 10:1076\u20131078","journal-title":"Neurology"},{"key":"2244_CR125","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.5144","author":"Y Orlova","year":"2018","unstructured":"Orlova Y, Rizzoli P, Loder E (2018) Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitors or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2017.5144","journal-title":"JAMA Neurol"},{"key":"2244_CR126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0924-9338(03)00090-7","volume":"18","author":"W Otte","year":"2003","unstructured":"Otte W, Birkenhager TK, van den Broek VWV (2003) Fatal interaction between tranylcypromine and imipramine. Eur Psychiatry 18:264\u2013265","journal-title":"Eur Psychiatry"},{"key":"2244_CR127","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinane.2007.06.024","volume":"20","author":"S Ozkardesler","year":"2008","unstructured":"Ozkardesler S, Gurpinar T, Akan M et al (2008) A possible perianesthetic serotonin syndrome related to intrathecal fentanyl. J Clin Anesth 20:143\u2013145","journal-title":"J Clin Anesth"},{"key":"2244_CR128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.euroneuro.2011.06.002","volume":"22","author":"V Parks","year":"2012","unstructured":"Parks V, Philipp AW, Raje S et al (2012) Concomitant blockade of 5-HT1A receptor and 5-HT transporter: use of the hunter serotonin toxicity criteria in a clinical pharmacology study. Eur Neuropsychopharmacol 22:92\u201399","journal-title":"Eur Neuropsychopharmacol"},{"key":"2244_CR129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/201010581102000311","volume":"20","author":"S Pothiawala","year":"2011","unstructured":"Pothiawala S, Ponampalam R (2011) Tramadol overdose: a case report. Proc Singap Healthc 20:219\u2013223","journal-title":"Proc Singap Healthc"},{"key":"2244_CR130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0885-3924(93)90101-Z","volume":"8","author":"R P\u00f6yhi\u00e4","year":"1993","unstructured":"P\u00f6yhi\u00e4 R, Vainio A, Kalso E (1993) A review of oxycodone\u2019s clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manage 8:63\u201367","journal-title":"J Pain Symptom Manage"},{"key":"2244_CR131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1054\/mehy.2000.1047","volume":"55","author":"JW Radomski","year":"2000","unstructured":"Radomski JW, Dursun SM, Reveley MA et al (2000) An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 55:218\u2013224","journal-title":"Med Hypotheses"},{"key":"2244_CR132","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","volume":"260","author":"RB Raffa","year":"1992","unstructured":"Raffa RB, Friderichs E, Reimann W et al (1992) Opioid and non-opioid components independently contribute to the mechanism of action of tramadol an \u2018atypical\u2019 opioid analgesic. J Pharmacol Exp Ther 260:275\u2013285","journal-title":"J Pharmacol Exp Ther"},{"key":"2244_CR133","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/14656566.2012.696097","volume":"13","author":"RB Raffa","year":"2012","unstructured":"Raffa RB, Buschmann H, Christoph T et al (2012) Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother 13:1437\u20131449","journal-title":"Expert Opin Pharmacother"},{"key":"2244_CR134","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/anae.13080","volume":"70","author":"S Ramaswamy","year":"2015","unstructured":"Ramaswamy S, Chang S, Mehta V (2015) Tapentadol\u2014the evidence so far. Anaesthesia 70:518\u2013522","journal-title":"Anaesthesia"},{"key":"2244_CR135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF03016672","volume":"55","author":"ST Rang","year":"2008","unstructured":"Rang ST, Field J, Irving C (2008) Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 55:521\u2013525","journal-title":"Can J Anaesth"},{"key":"2244_CR136","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/ALN.0b013e31823940c0","volume":"115","author":"R Rastogi","year":"2011","unstructured":"Rastogi R, Swarm RA, Patel TA (2011) Case scenario: opioid association with serotonin syndrome. Implications to the practitioners. Anesthesiology 115:1291\u20131298","journal-title":"Anesthesiology"},{"issue":"Suppl 2","key":"2244_CR137","doi-asserted-by":"crossref","first-page":"D119","DOI":"10.1016\/j.encep.2009.03.010","volume":"36","author":"M Reich","year":"2010","unstructured":"Reich M, Lefebvre-Kuntz D (2010) Serotonergic antidepressants and opiate analgesics: a sometimes-painful association. A case report. (Article in French). Encephale 36(Suppl 2):D119\u2013D123","journal-title":"Encephale"},{"key":"2244_CR138","first-page":"1742","volume":"35","author":"W Richter","year":"1985","unstructured":"Richter W, Barth H, Floh\u00e9 L et al (1985) Clinical investigation on the development of dependence during oral therapy with tramadol. Arzneimittelforschung 35:1742\u20131744","journal-title":"Arzneimittelforschung"},{"key":"2244_CR139","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bph.14105","volume":"175","author":"A Rickli","year":"2018","unstructured":"Rickli A, Liakoni E, Hoener M et al (2018) Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. Br J Pharmacol 175:532\u2013543","journal-title":"Br J Pharmacol"},{"key":"2244_CR140","first-page":"85","volume":"103","author":"N Rivers","year":"1970","unstructured":"Rivers N (1970) Possible lethal reaction between Nardil and dextromethorphan. Can Med Assoc J 103:85","journal-title":"Can Med Assoc J"},{"key":"2244_CR141","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1476-5381.1969.tb08003.x","volume":"36","author":"KJ Rogers","year":"1969","unstructured":"Rogers KJ, Thornton JA (1969) The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice. Br J Pharm 36:470\u2013480","journal-title":"Br J Pharm"},{"key":"2244_CR142","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/00912700122009926","volume":"41","author":"CJ Rosebraugh","year":"2001","unstructured":"Rosebraugh CJ, Flockhart DA, Yasuda SU et al (2001) Visual hallucination and tremor induced by sertraline and oxycodone in a bone marrow transplant patient. J Clin Pharmacol 41:224\u2013227","journal-title":"J Clin Pharmacol"},{"key":"2244_CR143","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1592\/phco.19.1.88.30515","volume":"19","author":"GE Ruoff","year":"1999","unstructured":"Ruoff GE (1999) Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 19:88\u201393","journal-title":"Pharmacotherapy"},{"key":"2244_CR144","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1310\/hpx5204-248","volume":"52","author":"M Russo","year":"2017","unstructured":"Russo M, Santarelli D, Isbister G (2017) Comment on \u201cprobable tapentadol-associated serotonin syndrome after overdose\u201d. Hosp Pharm 52:248","journal-title":"Hosp Pharm"},{"key":"2244_CR145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/15563650.2015.1036279","volume":"53","author":"NM Ryan","year":"2015","unstructured":"Ryan NM, Isbister GK (2015) Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol 53:545\u2013550","journal-title":"Clin Toxicol"},{"key":"2244_CR146","first-page":"382","volume":"63","author":"L Samoy","year":"2010","unstructured":"Samoy L, Shalansky K (2010) Interaction between methadone and ciprofloxacin. Can J Hosp Pharm 63:382\u2013384","journal-title":"Can J Hosp Pharm"},{"key":"2244_CR147","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/026988119801200201","volume":"12","author":"P Schloss","year":"1998","unstructured":"Schloss P, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115\u2013121","journal-title":"J Psychopharmacol"},{"key":"2244_CR148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)09485-6","volume":"273","author":"R Schreiber","year":"1995","unstructured":"Schreiber R, Brocco M, Audinot V et al (1995) (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273:101\u2013112","journal-title":"J Pharmacol Exp Ther"},{"key":"2244_CR149","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00002018-199207030-00005","volume":"7","author":"SA Schug","year":"1992","unstructured":"Schug SA, Zech D, Grond S (1992) Adverse effects of systemic opioids analgesics. Drug Saf 7:200\u2013213","journal-title":"Drug Saf"},{"key":"2244_CR150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/15563650701668625","volume":"46","author":"AR Schwartz","year":"2008","unstructured":"Schwartz AR, Pizon AF, Brooks DE (2008) Dextromethorphan-induced serotonin syndrome. Clin Toxicol 46:771\u2013773","journal-title":"Clin Toxicol"},{"key":"2244_CR151","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0960327108090270","volume":"27","author":"S Shadnia","year":"2008","unstructured":"Shadnia S, Soltaninejad K, Heydari K et al (2008) Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol 27:201\u2013205","journal-title":"Hum Exp Toxicol"},{"key":"2244_CR152","doi-asserted-by":"crossref","first-page":"562","DOI":"10.12659\/AJCR.892264","volume":"15","author":"M Shakoor","year":"2014","unstructured":"Shakoor M, Ayub S, Ahad A et al (2014) Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor. Am J Case Rep 15:562\u2013564","journal-title":"Am J Case Rep"},{"key":"2244_CR153","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0735-6757(94)90031-0","volume":"12","author":"BP Skop","year":"1994","unstructured":"Skop BP, Finkelstein JA, Mareth TR et al (1994) The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 12:642\u2013644","journal-title":"Am J Emerg Med"},{"key":"2244_CR154","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0091-3057(86)90477-6","volume":"24","author":"LM Smith","year":"1986","unstructured":"Smith LM, Peroutka SJ (1986) Differential effects of 5-hydroxytryptamine selective drugs on the 5-HT behavioral syndrome. Pharmacol Biochem Behav 24:1513\u20131519","journal-title":"Pharmacol Biochem Behav"},{"key":"2244_CR155","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMc0706410","volume":"358","author":"OP Soldin","year":"2008","unstructured":"Soldin OP, Tonning JM (2008) Serotonin syndrome associated with triptan monotherapy. N Eng J Med 358:2185\u20132186","journal-title":"N Eng J Med"},{"key":"2244_CR156","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.36076\/ppj.2013\/16\/E632","volume":"16","author":"H-K Song","year":"2013","unstructured":"Song H-K (2013) Serotonin syndrome with perioperative oxycodone and pregabalin. Pain Physician 16:E632\u2013E633","journal-title":"Pain Physician"},{"key":"2244_CR157","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/15563659709043367","volume":"35","author":"HA Spiller","year":"1997","unstructured":"Spiller HA, Gorman SE, Villalobos D et al (1997) Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol 35:361\u2013364","journal-title":"J Toxicol Clin Toxicol"},{"key":"2244_CR158","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","volume":"148","author":"H Sternbach","year":"1991","unstructured":"Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148:705\u2013713","journal-title":"Am J Psychiatry"},{"key":"2244_CR159","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/PCC.08l00690","volume":"11","author":"J Takeshita","year":"2009","unstructured":"Takeshita J, Litzinger MH (2009) Serotonin syndrome associated with tramadol. Prim Care Companion J Clin Psychiatry 11:273","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"2244_CR160","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/15563651003709427","volume":"48","author":"A Tashakori","year":"2010","unstructured":"Tashakori A, Afshari R (2010) Tramadol overdose as a cause of serotonin syndrome: a case series. Clin Toxicol 48:337\u2013341","journal-title":"Clin Toxicol"},{"issue":"7252","key":"2244_CR161","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(62)90256-8","volume":"280","author":"DC Taylor","year":"1962","unstructured":"Taylor DC (1962) Alarming reaction to pethidine in patients on phenelzine. Lancet 280(7252):401\u2013402","journal-title":"Lancet"},{"key":"2244_CR162","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/00000542-200306000-00033","volume":"98","author":"TA Tissot","year":"2003","unstructured":"Tissot TA (2003) Probable meperidine-induced serotonin syndrome in a patient with a history of fluoxetine use. Anesthesiology 98:1511\u20131512","journal-title":"Anesthesiology"},{"key":"2244_CR163","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.forsciint.2007.02.007","volume":"173","author":"M Tj\u00e4derborn","year":"2007","unstructured":"Tj\u00e4derborn M, J\u00f6nsson AK, H\u00e4gg S et al (2007) Fatal unintentional intoxications with tramadol during 1995\u20132005. Forensic Sci Int 173:107\u2013111","journal-title":"Forensic Sci Int"},{"key":"2244_CR164","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00007611-199708000-00010","volume":"90","author":"JD Tobias","year":"1997","unstructured":"Tobias JD (1997) Seizure after overdose of tramadol. South Med J 90:826\u2013827","journal-title":"South Med J"},{"key":"2244_CR165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(84)90714-3","volume":"106","author":"MD Tricklebank","year":"1984","unstructured":"Tricklebank MD, Forler C, Fozard JR (1984) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271\u2013282","journal-title":"Eur J Pharmacol"},{"key":"2244_CR166","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","volume":"323","author":"TM Tzschentke","year":"2007","unstructured":"Tzschentke TM, Christoph T, K\u00f6gel B et al (2007) (\u2212)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel \u00b5-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther 323:265\u2013276","journal-title":"J Pharmacol Exp Ther"},{"key":"2244_CR167","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1358\/dot.2009.45.7.1395291","volume":"45","author":"TM Tzschentke","year":"2009","unstructured":"Tzschentke TM, Jahnel U, Kogel B et al (2009) Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barc) 45:483\u2013496","journal-title":"Drugs Today (Barc)"},{"key":"2244_CR168","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/oxfordjournals.bja.a013453","volume":"84","author":"DS Ure","year":"2000","unstructured":"Ure DS, Gillies MA, James KS (2000) Safe use of remifentanil in a patient treated with the monoamine oxidase inhibitor phenelzine. Br J Anaesth 84:414\u2013416","journal-title":"Br J Anaesth"},{"key":"2244_CR169","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JPR.S14842","volume":"4","author":"N Vadivelu","year":"2011","unstructured":"Vadivelu N, Timchenko A, Huang Y et al (2011) Tapentadol extended-release for treatment of chronic pain: a review. J Pain Res 4:211\u2013218","journal-title":"J Pain Res"},{"key":"2244_CR170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.04.007","volume":"80","author":"U Verthein","year":"2005","unstructured":"Verthein U, Ullman R, Lachmann A et al (2005) The effects of racemic D,L-methadone and L-methadone in substituted patients\u2014a randomized controlled study. Drug Alcohol Depend 80:267\u2013271","journal-title":"Drug Alcohol Depend"},{"key":"2244_CR171","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aem325","volume":"99","author":"MP Vizcaychipi","year":"2007","unstructured":"Vizcaychipi MP, Walker S, Palazzo M (2007) Serotonin syndrome triggered by tramadol. Br J Anaesth 99:919","journal-title":"Br J Anaesth"},{"key":"2244_CR172","first-page":"533","volume":"13","author":"J Volpi-Abadie","year":"2013","unstructured":"Volpi-Abadie J, Kaye AM, Kaye AD (2013) Serotonin syndrome. Ochsner J 13:533\u2013540","journal-title":"Ochsner J"},{"key":"2244_CR173","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1360-0443.2003.00292.x","volume":"98","author":"E Vuori","year":"2003","unstructured":"Vuori E, Henry JA, Ojanpera I et al (2003) Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction 98:365\u2013368","journal-title":"Addiction"},{"issue":"4","key":"2244_CR174","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1310\/hpj5104-320","volume":"51","author":"Heather Walczyk","year":"2016","unstructured":"Walczyk H, Liu CH, Alafris A et al (2016) Probable tapentadol-associated serotonin syndrome after overdose. Hosp Pharm 51:320\u2013327","journal-title":"Hospital Pharmacy"},{"key":"2244_CR175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bjp.0706351","volume":"146","author":"J Walkembach","year":"2005","unstructured":"Walkembach J, Br\u0171ss M, Urban BW et al (2005) Interaction of metoclopramide and ergotamine with human 5-HT3A receptors and human 5-HT reuptake carriers. Br J Pharmacol 146:543\u2013552","journal-title":"Br J Pharmacol"},{"key":"2244_CR176","doi-asserted-by":"publisher","first-page":"261787","DOI":"10.1155\/2012\/261787","volume":"2012","author":"C Walter","year":"2012","unstructured":"Walter C, Ball D, Duffy M et al (2012) An unusual case of serotonin syndrome with oxycodone and citalopram. Case Rep Oncol Med 2012:261787. https:\/\/doi.org\/10.1155\/2012\/261787","journal-title":"Case Rep Oncol Med"},{"key":"2244_CR177","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1553-2712.1999.tb01056.x","volume":"6","author":"AL Weiner","year":"1999","unstructured":"Weiner AL (1999) Meperidine as a potential cause of serotonin syndrome in the emergency department. Acad Emerg Med 6:56\u201358","journal-title":"Acad Emerg Med"},{"key":"2244_CR178","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12883-016-06161","volume":"16","author":"U Werneke","year":"2016","unstructured":"Werneke U, Jamshidi F, Taylor DM et al (2016) Conundrums in neurology: diagnosing serotonin syndrome\u2014a meta-analysis of cases. BMC Neurol 16:97. https:\/\/doi.org\/10.1186\/s12883-016-06161","journal-title":"BMC Neurol"},{"key":"2244_CR179","first-page":"103","volume-title":"Medical toxicology","author":"IM Whyte","year":"2004","unstructured":"Whyte IM (2004) Serotonin syndrome (toxicity). In: Dart RC (ed) Medical toxicology, 3rd\u00a0edn., vol. 1. Lippincott Williams and Wilkens, Baltimore, pp\u00a0103\u2013106","edition":"3"},{"key":"2244_CR180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1213\/ane.0b013e31817342c2","volume":"107","author":"M Wittmann","year":"2008","unstructured":"Wittmann M, Schaaf T, Peters I et al (2008) The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesth Analg 107:107\u2013112","journal-title":"Anesth Analg"},{"key":"2244_CR181","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0028-3908(83)90123-5","volume":"22","author":"CY Yap","year":"1983","unstructured":"Yap CY, Taylor DA (1983) Involvement of 5-HT2 receptors in the wet-dog shake behavior induced by 5-hydroxytryptamine in the rat. Neuropharmacol 22:801\u2013804","journal-title":"Neuropharmacol"},{"key":"2244_CR182","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103\u2013141","journal-title":"Pharmacol Ther"},{"key":"2244_CR183","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0140-6736(91)92219-R","volume":"337","author":"GL Zornberg","year":"1991","unstructured":"Zornberg GL, Bodkin JA, Cohen BM (1991) Severe adverse interaction between pethidine and selegilene. Lancet 337:246","journal-title":"Lancet"},{"key":"2244_CR184","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1742-7843.2009.00378.x","volume":"104","author":"ST Zwisler","year":"2009","unstructured":"Zwisler ST, Enggaard TP, Noehr-Jensen L et al (2009) The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism. Basic Clin Pharmacol Toxicol 104:335\u2013344","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-018-2244-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-018-2244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-018-2244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:44:00Z","timestamp":1751676240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-018-2244-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":184,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2244"],"URL":"https:\/\/doi.org\/10.1007\/s00204-018-2244-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"4 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author, Brian A. Baldo, declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}